Towards an Atlas of Human Helminth Infection in sub-saharan Africa: The Use of Geographical Information Systems (GIS)

Similar documents
AIDS in Africa. An Update. Basil Reekie

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

Impact of Pathology Implementation Strategies in Sub Saharan Africa

IMMUNIZATION & VACCINE PREVENTABLE DISEASES

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

Annex 2 A. Regional profile: West Africa

Scaling Up Nutrition Action for Africa

IMMUNIZATION VACCINES & EMERGENCIES

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

ASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

AFRICA. The continent of All challenges

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

Excellence and Originality from Necessity: Palliative Care in Africa. Dr Emmanuel Luyirika Executive Director, African Palliative Care Association

Schistosomiasis Alan Fenwick

CANCER OF THE CERVIX IN THE AFRICAN REGION: CURRENT SITUATION AND WAY FORWARD

What is this document and who is it for?

1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.

Common EQA Mistakes - A provider Perspective. Experience from East African Regional External Quality Assessment Scheme (EA-REQAS)

UNAIDS 2013 AIDS by the numbers

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

IMMUNIZATION VACCINE DEVELOPMENT

Gender, Poverty, and Health in Sub-Saharan Africa: A Framework for Analysis

TFI Proceedings, Recommendations and implications for 2005

ASLM Building laboratory capacity in Africa in a sustainable way

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

Demographic Transitions, Solidarity Networks and Inequality Among African Children: The Case of Child Survival? Vongai Kandiwa

! Multisectoral Information, Data, Research & Evidence - for Health, Population, Human & Social Development!

Health situation analysis in the African Region. Basic indicators 2006

What is the recent experience of programs that distribute contraceptives free of charge versus for a price?

Food Production and Violent Conflict in Sub-Saharan Africa. - Supplementary Information -

MEASLES ELIMINATION BY 2020: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat. Executive Summary

Children in Africa. Key statistics on child survival, protection and development

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

Measles Supplementary Immunization Activities and GAVI Funds as Catalysts for Improving Injection Safety in Africa

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

Status Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa

Ageing and mental health resources for older persons in the African region of the World Health Organization

Global reductions in measles mortality and the risk of measles resurgence

Aboubacar Kampo Chief of Health UNICEF Nigeria

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Plan of Presentation

Africa s slow fertility transition

Tracking Progress in Scaling-Up Diagnosis and Treatment for Malaria

Eligibility List 2018

Age-Sex Structure for Selected African countries in the early 2000s

O c t o b e r 1 0,

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Ouagadougou Declaration

Blood safety in Africa: Progress made during the last decade and major challenges for the Future

Comparative Analyses of Adolescent Nutrition Indicators

Health systems and HIV: advocacy. Interagency Coalition on AIDS and Development

Overview of WHO/UNICEF Immunization Coverage Estimates

Financing the HIV response in sub- Saharan Africa from domestic sources: moving beyond a normative approach

Prioritizing Emergency Polio Eradication Activities

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Rotavirus vaccines: Issues not fully addressed in efficacy trials

Global summary of the AIDS epidemic, December 2007

PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS AND THE POST 2015 HEALTH DEVELOPMENT AGENDA. Report of the Secretariat CONTENTS ANNEXES

Okwen PM 1,2, Maweu IW 1,3, Ndimbum CN 1, Evina Danielle 2 Ongolo-Zogo Pierre 2, George Nel 4, Anastase Dzudzie 4, Dike Orji 4, Mayosi Bongani 4

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

Biosecurity, biobanking and data management during public health crises in Africa. A peer into the future.

511,000 (57% new cases) ~50,000 ~30,000

Progress has been made with respect to health conditions.

THE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

CREOLE Study: Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans. CREOLE Study

DG ECHO Funding on Humanitarian Food Assistance and Nutrition. January-December 2016 Overall Analysis

Expert Group Meeting on the Regional Report for the African Gender and Development Index

THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL: 10 YEARS OF IMPLEMENTATION IN THE AFRICAN REGION

Expert Paper No. 2011/13

THE DOUBLE DIVIDEND. Presented at 6 th HIV Paediatric Workshop, Melbourne 19 th July 2014

40 years of childhood vaccination programmes in Africa. Mind the gap

IMMUNIZATION VACCINE DEVELOPMENT

AFRICAN GENDER EQUALITY AND WOMEN S EMPOWERMENT SCORECARD

Specific issues related to FMD surveillance in the eastern Africa sub-region. Gideon Brückner

Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality

ENHANCING THE ROLE OF TRADITIONAL MEDICINE IN HEALTH SYSTEMS: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat EXECUTIVE SUMMARY

Fertility and Family Planning in Africa: Call for Greater Equity Consciousness

PROGRESS REPORT ON DECADE OF TRADITIONAL MEDICINE IN THE AFRICAN REGION. Progress Report. CONTENTS Paragraphs BACKGROUND PROGRESS MADE...

Incorporating combination polypharmacy into national or provincial CVD control strategies: An African perspective

World Toilet Day: Eradicating open defecation still a challenge in Ghana

The Schistosomiasis Control Initiative (SCI) Professor Alan Fenwick

REGIONAL OVERVIEW AND PERSPECTIVES ON SOCIAL DETERMINANTS OF HEALTH IN AFRICA

Financing malaria control

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

Foreword. For further information please contact Dr Nivo Ramanandraibe at and Dr Ahmed E. Ogwell Ouma at

THE CARE WE PROMISE FACTS AND FIGURES 2017

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

Race towards Sustainab. MD, PhD, FRSPH

Global Fund ARV Fact Sheet 1 st June, 2009

TURNING POINT FOR AFRICA AN HISTORIC OPPORTUNITY TO END AIDS AS A PUBLIC HEALTH THREAT BY 2030 AND LAUNCH A NEW ERA OF SUSTAINABILITY

Global Polio Eradication Initiative

Tipping the dependency

Procedure for Expedited Review of imported pre-qualified vaccines for use in national immunization programmes

Update from GAVI Aurelia Nguyen

The Impact of Population Policies, Non-Governmental Organizations, and HIV/AIDS Policies on Fertility and HIV Prevalence in Sub-Saharan Africa 1

Transcription:

Towards an Atlas of Human Helminth Infection in sub-saharan Africa: The Use of Geographical Information Systems (GIS) S. Brooker, M. Rowlands, L. Haller, L. Savioli and D.A.P. Bundy * *Ndir, O. et al. (1996) Enquete Nationale sur la Bilharziose au Senegal. Universite Cheikh anta Diop de Dakar. Simon Brooker, Megan Rowlands, Laurence Haller and Don Bundy are at the WHO Collaborating Centre, Wellcome Trust Centre for the Epidemiology of Infectious Disease, University of Oxford, South Parks Road, Oxford, UK OX1 3FY. Lorenzo Savioli is at the World Health Organization, 1211, Geneva 27, Switzerland. Tel: +44 1865 281232, Fax: +44 1865 281245, e-mail: simon.brooker@ceid.ox.ac.uk Parasitology Today, vol. 16, no. 7, 2000 0169-4758/00/$ see front matter 2000 Elsevier Science Ltd. All rights reserved. PII: S0169-4758(00)01687-2 303

Table 1. An African helminth database for sub-saharan Africa a,b No. No. No. of admin % of admin units for which there are data Country refs surveys units in country Schistosomiasis Geohelminths Both Angola c 3 39 48 10.4 2.1 0.0 Benin 6 60 77 16.9 2.6 1.3 Botswana 10 179 10 80.0 30.0 30.0 Burkina Faso 19 75 301 15.6 0.3 0.3 Burundi 8 16 15 26.7 13.3 13.3 C.A.R. 6 50 51 45.1 45.1 45.1 Cameroon 28 143 49 100.0 100.0 100.0 Congo 20 80 46 17.4 4.3 4.3 DR Congo 7 95 38 18.4 13.2 13.2 Equatorial Guinea c 2 5 7 0.0 14.3 0.0 Ethiopia 50 234 94 20.7 12.4 12.4 Eritrea d 2 2 38 0.0 0.0 0.0 Gabon 13 47 46 15.2 2.2 0.0 Gambia 6 14 37 2.7 8.1 2.7 Ghana c 11 57 10 30.0 70.0 20.0 Guinea 4 25 33 36.4 36.4 36.4 Guinea Bissau 1 1 37 0.0 2.7 0.0 Ivory coast 17 76 50 36.0 18.0 12.0 Kenya 45 88 47 29.8 25.5 21.3 Liberia 10 83 54 7.4 24.1 3.7 Madagascar 28 286 111 21.6 15.3 15.3 Malawi 4 42 24 83.3 4.2 0.0 Mali 24 579 46 78.3 4.3 4.3 Mauritania 8 93 44 56.8 4.5 4.5 Mozambique 4 4 128 4.7 0.7 0.0 Namibia c 6 28 26 11.5 11.5 11.5 Niger 16 57 35 31.4 5.7 5.7 Nigeria c 54 156 31 48.4 48.4 41.9 Rwanda c 3 5 10 10.0 20.0 10.0 Senegal 15 300 30 80.0 10.0 10.0 Sierra Leone 9 23 15 53.3 13.3 13.3 Somalia c 13 39 16 25.0 25.0 18.8 Sudan 10 50 18 27.8 5.6 5.6 Tanzania 55 110 97 38.1 37.1 25.8 Tchad 3 9 14 42.9 28.6 28.6 Togo c 4 66 5 80.0 20.0 20.0 Uganda 26 91 46 71.7 56.5 60.9 Zambia 23 97 97 19.6 4.1 4.1 Zimbabwe 14 119 57 94.7 5.3 5.3 Total 583 3486 2304 29.7 14.9 12.6 a This work in progress has currently identified data from 39 countries. Where possible, the prevalence data are associated with a specific district within a country, but see c. b Countries in North Africa were not included because of the concentration of disease burden as a result of helminth infection in sub-saharan Africa. South Africa, Swaziland and Lesotho are temporarily excluded while we await publication of a separate GIS analysis of helminths for these countries. c The administrative unit is the region. d Not possible to assign survey data to specific admin units. 304 Parasitology Today, vol. 16, no. 7, 2000

Table 2. Independent estimates of prevalence of the major helminth infections in sub-saharan Africa a over the past 50 years S. haematobium S. mansoni A. lumbricoides T. trichiura Hookworm b Stoll (1947) 17 26.5 15.5 39.9 18.9 33.1 Crompton and Tulley (1987) 14 32.3 Utroska et al. (1989) 15 25.5 c Bundy et al. (1998) 3 20.3 16.6 26.9 Weighted current estimates d Prevalence (%) 25.9 18.3 26.7 20.9 33.0 Total number surveyed 827 986 672 057 361166 317 359 394 983 Prevalence in school-aged 27.4 14.0 30.2 29.5 32.1 children (%) Number of school-aged 514 679 330 533 165 599 136 331 190 932 children surveyed Cases (million) e 131 98 161 100 192 a Defined as the Global Burden of Disease Study 3, but excludes South Africa, Swaziland and Lesotho. b Both Necator americanus and Anclyostoma duodenale. c Combined Schistosoma haematobium and S. mansoni. d Estimates are for both sexes combined. Estimates are based on prevalences for each country in the database. e Based on 2000 population estimates [US Census Bureau (1999). International Data Base]. * * Parasitology Today, vol. 16, no. 7, 2000 305

Fig. 1. Maps are shown detailing geohelminths in Africa: Ascaris, Trichuris and hookworm by district (a) and schistosomiasis in Africa: Schistosoma mansoni and S. haematobium by district (b). The geohelminth species with the highest prevalence is taken to represent the prevalence of geohelminth infection. Similarly, the schistosome species with the highest prevalence is taken to represent the total prevalence of schistosome infection. The maps show data for sub-saharan Africa only. Of the 2304 administrative units (usually districts) in 39 countries, data are available for schistosomiasis in 684 (29.7%) and for geohelminths in 343 (14.9%). However, the population in Africa is not homogeneously distributed, and many of the districts for which no data are currently available also have low-density populations. To highlight the high population density areas of Africa we have created a template that masks out all districts with population density 5 people per km 2 and between 5 and 20 people per km 2. The atlas is also available at http://www.ceid.ox.ac.uk/child/. 306 Parasitology Today, vol. 16, no. 7, 2000

Acknowledgements The atlas is a work in progress and hence the estimates provided are preliminary. Revision and improvement require further information on the prevalence of infection within countries. If you know of relevant data that could be included, or if you would like to be a partner in this initiative, then please contact the WHO in Geneva. Collaborating partners include the Strategy Development and Monitoring for Parasitic Diseases and Vector Control, Communicable Disease Control, Prevention and Eradication, World Health Organization, 1211, Geneva 27 (Dirk Engels, Lester Chitsulo and Antonio Montreso); the WHO/UNICEF Joint Programme on Health Mapping and GIS, HealthMap (Kathy O Neill, Jean-Pierre Meert and Isabelle Nutall); and the Partnership for Child Development and the International School Health Initiative of the World Bank. The Partnership is supported by the United Nations Development Programme, the Rockefeller Foundation, the Edna McConnell Clark Foundation, the James S. McDonnell Foundation, the Wellcome Trust, the World Bank, UNICEF, and the WHO. SB is in receipt of a Wellcome Trust Prize Studentship. DAPB acknowledges the financial support of the Wellcome Trust. We are grateful to Andrew Hall, Simon Hay and Edwin Michael for useful discussions and comments, and thank Michael Beasley and Jonathan Toomer for invaluable assistance in data preparation. Microsatellite Markers and Genetic Mapping in Plasmodium falciparum Michael Ferdig and Xin-zhuan Su are at the Laboratory of Parasitic Diseases, National Institutes of Health, 4 Center Drive 0425, Bethesda, MD 20892-0425, USA. Tel: +1 301 496 4023, Fax: +1 301 402 0079, e-mail: xsu@helix.nih.gov M.T. Ferdig and X-z. Su Parasitology Today, vol. 16, no. 7, 2000 0169-4758/00/$ see front matter 2000 Elsevier Science Ltd. All rights reserved. PII: S0169-4758(00)01676-8 307